1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Bioinformatics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product and Service
6.1 Knowledge Management Tools
6.1.1 Market Trends
6.1.2 Major Types
6.1.2.1 Generalized Knowledge Management Tools
6.1.2.2 Specialized Knowledge Management Tools
6.1.3 Market Forecast
6.2 Bioinformatics Platforms
6.2.1 Market Trends
6.2.2 Major Types
6.2.2.1 Surgical Simulation Platforms
6.2.2.2 Sequence Analysis, Alignment and Manipulation Platforms
6.2.2.3 Structural and Functional Analysis Platforms
6.2.2.4 Others
6.2.3 Market Forecast
6.3 Bioinformatics Services
6.3.1 Market Trends
6.3.2 Major Types
6.3.2.1 Data Analysis Services
6.3.2.2 Database Management Services
6.3.2.3 Others
6.3.3 Market Forecast
7 Market Breakup by Application
7.1 Genomics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Chemoinformatics and Drug Design
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Proteomics
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Transcriptomics
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Metabolomics
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Other Applications
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by End-Use Sector
8.1 Medical Biotechnology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Academics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Animal Biotechnology
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Agricultural Biotechnology
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Environmental Biotechnology
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Forensic Biotechnology
8.6.1 Market Trends
8.6.2 Market Forecast
8.7 Others
8.7.1 Market Trends
8.7.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 ABM Industries
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Agilent Technologies
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.3 Biomax Informatics
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.4 Data4cure Inc.
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.5 Dnastar Inc.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.6 Illumina Inc.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 Life Technologies
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.8 Perkinelmer Inc.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Qiagen N.V.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.10 Quest Diagnostics
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Sophia Genetics SA
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.12 Thermo Fisher Scientific Inc.
13.3.12.1 Company Overview
13.3.12.2 Product Portfolio
13.3.12.3 Financials
13.3.12.4 SWOT Analysis
13.3.13 Waters Corporation
13.3.13.1 Company Overview
13.3.13.2 Product Portfolio
13.3.13.3 Financials
13.3.13.4 SWOT Analysis
13.3.14 WuXi Nextcode Genomics
13.3.14.1 Company Overview
13.3.14.2 Product Portfolio
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/